PIH Health Good Samaritan Hospital is a hospital in Los Angeles, California. The hospital has 408 beds. In 2019 Good Samaritan joined the PIH Health network.

There are 408 beds in Good Samaritan Hospital.

During the past decade, Good Samaritan Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 15 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Good Samaritan Hospital" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Biosense Webster, Inc." with 3 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Forest Laboratories" with 3 trials sponsored and "C. R. Bard" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Good Samaritan Hospital" #1 collaborator was "Abbott Medical Devices" with 2 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 2 trials as a collaborator, "Christiana Care Health Services" with 2 trials as a collaborator, "John H. Stroger Hospital" with 2 trials as a collaborator and "LAC+USC Medical Center" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Good Samaritan Hospital" are "Atrial Fibrillation" (6 trials), "Coronary Artery Disease" (5 trials), "Arrhythmia" (3 trials), "Peripheral Artery Disease" (3 trials) and "Coronary Artery Stenosis" (2 trials). Many other conditions were trialed in "Good Samaritan Hospital" in a lesser frequency.

Most popular intervention types in "Good Samaritan Hospital" are "Device" (20 trials), "Drug" (11 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Azimilide Dihydrochloride" (3 trials), "Placebo" (3 trials), "AMPLATZER Cardiac Plug" (1 trials), "Abbott Mitraclip System" (1 trials) and "Ablation Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Good Samaritan Hospital" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Good Samaritan Hospital". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Good Samaritan Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Good Samaritan Hospital, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 14 trials that are defined as “Not Applicable".